BTIG Upgrades Neogenomics (NEO) to Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. SPY

Go back to BTIG Upgrades Neogenomics (NEO) to Buy

NeoGenomics Reports 142% Revenue Growth to $60.8 Million and a Record $9.6 Million in Cash Flow from Operations in the Third Quarter of 2016

October 26, 2016 7:00 AM EDT

FT. MYERS, Fla., Oct. 26, 2016 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the third quarter of 2016.

Third Quarter 2016 Highlights:

142% increase in consolidated revenue to $60.8 million 150% increase in clinical genetic testing volume(1) Diluted EPS of ($0.07) per share and Adjusted Diluted EPS(2) of $0.04 per share Year-to-date cash flow from operations of $21.7 million

Consolidated revenue for the third quarter was $60.8 million, an increase of 142% over the same period last... More